-
Tytuł:
-
Benign lymphoproliferative disorders in the immunosuppressed patient: an update.
-
Autorzy:
-
Robinson L; Department of Oral Biology and Oral Pathology, School of Dentistry, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
Fonseca FP; Department of Oral Biology and Oral Pathology, School of Dentistry, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.; Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
van Heerden WFP; Department of Oral Biology and Oral Pathology, School of Dentistry, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
-
Źródło:
-
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology [J Oral Pathol Med] 2021 Jul; Vol. 50 (6), pp. 540-547. Date of Electronic Publication: 2021 Jun 24.
-
Typ publikacji:
-
Journal Article; Review
-
Język:
-
English
-
Imprint Name(s):
-
Publication: Oxford, UK : Wiley-Blackwell
Original Publication: Copenhagen : Munksgaard, c1989-
-
MeSH Terms:
-
Epstein-Barr Virus Infections*/complications
Herpesvirus 8, Human*
Lymphoproliferative Disorders*
Herpesvirus 4, Human ; Humans
-
References:
-
Naresh KN. Lymphoproliferative disorders in the immunosuppressed. Diagn Histopathol. 2010;16:206-215.
Natkunam Y, Gratzinger D, Chadburn A, et al. Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal? Blood. 2018;132:1871-1878.
Swerdlow SH, World Health Organization, International Agency for Research on C. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th ed. Lyon, France: International Agency for Research on Cancer; 2017.
Du MQ, Diss TC, Liu H, et al. KSHV- and EBV-associated germinotropic lymphoproliferative disorder. Blood. 2002;100:3415-3418.
Wang W, Kanagal-Shamanna R, Medeiros LJ. Lymphoproliferative disorders with concurrent HHV8 and EBV infection: beyond primary effusion lymphoma and germinotropic lymphoproliferative disorder. Histopathology. 2018;72:855-861.
Natkunam Y, Gratzinger D, de Jong D, et al. Immunodeficiency and dysregulation: Report of the 2015 Workshop of the Society for Hematopathology/European Association for Haematopathology. Am J Clin Pathol. 2017;147:124-128.
Marques-Piubelli ML, Salas YI, Pachas C, Becker-Hecker R, Vega F, Miranda RN. Epstein-Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: a review. Pathology. 2020;52:40-52.
Jaffe ES, Arber DA, Campo E, Harris NL. Quintanilla-Martinez L Hematopathology. Philadelphia, PA: Elsevier; 2017.
Wenig BM, Thompson LD, Frankel SS, et al. Lymphoid changes of the nasopharyngeal and palatine tonsils that are indicative of human immunodeficiency virus infection. A clinicopathologic study of 12 cases. Am J Surg Pathol. 1996;20:572-587.
McArthur CP, Subtil-DeOliveira A, Palmer D, et al. Characteristics of salivary diffuse infiltrative lymphocytosis syndrome in West Africa. Arch Pathol Lab Med. 2000;124:1773-1779.
Ghrenassia E, Martis N, Boyer J, Burel-Vandenbos F, Mekinian A, Coppo P. The diffuse infiltrative lymphocytosis syndrome (DILS). A comprehensive review. J Autoimmun. 2015;59:19-25.
Meer S. Human immunodeficiency virus and salivary gland pathology: an update. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;128:52-59.
Dojcinov SD, Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES. EBV Positive Mucocutaneous Ulcer - A study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol. 2010;34:405-417.
Attard AA, Praveen P, Dunn PJ, James GJ. Epstein-Barr virus-positive mucocutaneous ulcer of the oral cavity: the importance of having a detailed clinical history to reach a correct diagnosis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114:e37-e39.
Onafowokan O, Rodgers W, Gruber E. Epstein-Barr virus-positive mucocutaneous ulcer of the oral cavity in a patient who had had a renal transplant. Br J Oral Maxillofac Surg. 2018;56:626-628.
Bahethi R, Gray M, Salib C, Likhterov I. Lymphoma mimicking chronic active epstein-barr virus: a case report. Head Neck Pathol. 2020;14:1028-1031.
Kimura H, Cohen JI. Chronic active Epstein-Barr virus disease. Front Immunol. 2017;8:1867.
Bunn B, van Heerden W. EBV-positive mucocutaneous ulcer of the oral cavity associated with HIV/AIDS. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120:725-732.
Hujoel IA, Rubio-Tapia A, Dao LN, Porrata LF, Kane SV. Epstein-Barr virus-positive mucocutaneous ulcer in an immunosuppressed patient. ACG Case Rep J. 2018;5:e32.
Hart M, Thakral B, Yohe S, et al. EBV-positive Mucocutaneous ulcer in organ transplant recipients: A localized indolent posttransplant lymphoproliferative disorder. Am J Surg Pathol. 2014;38:1522-1529.
Hirshberg A, Amariglio N, Akrish S, et al. Traumatic ulcerative granuloma with stromal eosinophilia: a reactive lesion of the oral mucosa. Am J Clin Pathol. 2006;126:522-529.
Zhong LP, Wang LZ, Ji T, et al. Clinical analysis of Castleman disease (hyaline vascular type) in parotid and neck region. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:432-440.
Xiao-dong L, Qiu-xu W, Wei-xian L. Castleman disease of the parotid gland: A case report. J Oral Maxillofac Surg. 2020;78:400.e1-400.e6.
Dispenzieri A, Fajgenbaum DC. Overview of Castleman disease. Blood. 2020;135:1353-1364.
Gratzinger D, de Jong D, Jaffe ES, et al. T- and NK-Cell lymphomas and systemic lymphoproliferative disorders and the immunodeficiency setting: 2015 SH/EAHP workshop report-part 4. Am J Clin Pathol. 2017;147:188-203.
Chadburn A, Said J, Gratzinger D, et al. HHV8/KSHV-Positive lymphoproliferative disorders and the spectrum of plasmablastic and plasma cell neoplasms: 2015 SH/EAHP Workshop Report-Part 3. Am J Clin Pathol. 2017;147:171-187.
Lattyak BV, Rosenthal P, Mudge C, et al. Posttransplant Lymphoproliferative disorder presenting in the head and neck. Laryngoscope. 1998;108(8 Pt 1):1195-1198.
Heyes R, Northfelt DW, Lott DG. Posttransplant lymphoproliferative disorder: Otolaryngological manifestations and management. Otolaryngol Head Neck Surg. 2017;157:750-759.
Vandjelovic ND, Barth PC, Dunn SP, Chikwava KR, Shah UK. Post-transplant lymphoproliferative disease of the larynx. J Surg Case Rep. 2019;2019:rjz111.
Sisi TMD, Christopher VMD, Justin CMSIV, Justin MMD, Miguel KDO. Early detection of post-transplant lymphoproliferative disorder by head and neck manifestations. J Hematol Oncol Res. 2016;2:1-6.
Campisi P, Allen UD, Ngan BY, Hawkes M, Forte V. Utility of head and neck biopsies in the evaluation of posttransplant lymphoproliferative disorder. Otolaryngol Head Neck Surg. 2007;37:296-300.
Akbas A, Tiede C, Lemound J, Maecker-Kolhoff B, Kreipe H, Hussein K. Post-transplant lymphoproliferative disorders with naso- and oropharyngeal manifestation. Transpl Int. 2015;28:1299-1307.
Leon JE, Takahama Junior A, Vassallo J, Soares FA, de Almeida OP, Lopes MA. EBV-associated polymorphic posttransplant lymphoproliferative disorder presenting as gingival ulcers. Int J Surg Pathol. 2011;19:241-246.
-
Contributed Indexing:
-
Keywords: EBV; HHV8; HIV; Lymphoproliferative disorder; immunosuppressed
-
Entry Date(s):
-
Date Created: 20210607 Date Completed: 20210719 Latest Revision: 20210719
-
Update Code:
-
20240104
-
DOI:
-
10.1111/jop.13204
-
PMID:
-
34097773
-
Immunosuppressed patients may be affected by a wide range of lymphoproliferative disorders (LPDs) ranging from self-limiting disorders to malignant lymphoid proliferations. These LPDs may be associated with systemic immune disorders, develop following organ transplantation or occur in the background of other forms of iatrogenic immunosuppression. Lymphotropic viruses, including Epstein-Barr virus (EBV) and human herpesvirus-8 (HHV8), have been associated with the pathogenesis of distinct LPDs. The resulting classification of this group of disorders is very complex and inconsistent, with several new and emerging entities. Consequently, the diagnosis of an LPD, especially in an immunosuppressed patient, and its subsequent clinical management usually represent an important pitfall in daily clinical and pathology work. Therefore, the aim of this review was to use the available literature to describe the clinicopathological features of the most important benign LPDs that may be diagnosed in the head and neck region of immunosuppressed patients. Original clinical and microscopic images were used to illustrate some of these entities.
(© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)